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Abstract 
Background 
Motivated patients are more likely to adhere to treatment resulting in better outcomes. Virtual reality 
rehabilitation (VRR) is a treatment approach that includes video gaming to enhance motivation and functional 
training. 
Aims 
The study objectives were (1) to evaluate the feasibility of using a combination of pelvic floor muscles (PFM) 
exercises and VRR (PFM/VRR) to treat mixed urinary incontinence (MUI) in older women, (2) to evaluate the 
effectiveness of the PFM/VRR program on MUI symptoms, quality of life (QoL), and (3) gather quantitative 
information regarding patient satisfaction with this new combined training program. 
Methods 
Women 65 years and older with at least 2 weekly episodes of MUI were recruited. Participants were evaluated 
two times before and one time after a 12-week PFM/VRR training program. Feasibility was defined as the 
participants' rate of participation in and completion of both the PFM/VRR training program and the home 
exercise. Effectiveness was evaluated through a bladder diary, pad test, symptom and QoL questionnaire, and 
participant's satisfaction through a questionnaire. 
Results 
Twenty-four women (70.5 ± 3.6 years) participated. The participants complied with the study demands in terms 
of attendance at the weekly treatment sessions (91%), adherence to home exercise (92%) and completion of the 
three evaluations (96%). Post-intervention, the frequency and quantity of urine leakage decreased and patient-
reported symptoms and QoL improved significantly. Most participants were very satisfied with treatment (91%). 
 
Conclusion 
A combined PFM/VRR program is an acceptable, efficient, and satisfying functional treatment for older women 
with MUI and should be explore through further RCTs.  
INTRODUCTION 
Pelvic floor muscle (PFM) training has shown efficacy and is the recommended first-line treatment for patients 
with stress (SUI), urge (UUI), or mixed (MUI) urinary incontinence.[1] Both individualized PFM treatments and 
group-based exercise classes have been shown to be effective in treating these types of UI, even in older 
women.[2-4] However, despite the effectiveness of PFM training, the potential and sustained benefits are 
frequently hindered by poor patient adherence, both in the short- and long-term, and has been identified as an 
important predictor of overall PFM effectiveness.[5, 6] 
Adherence to a regular PFM exercise program is key to its initial effectiveness[5, 6] and poor adherence to a 
maintenance exercise program is responsible for a decline in effect.[5, 7, 8] However, despite the low level of 
difficulty, non-invasiveness, and efficacy of PFM training, high attrition rates, and low adherence are well 
documented in both clinical and research settings[9]; as a result, adherence has been identified as an influential 
short- and long-term predictor of PFM exercise effectiveness.[6, 10] Motivation is key to adherence as motivated 
patients are more likely to adhere to treatment.[11] Thus, one of the greatest challenges for PFM 
physiotherapists is identifying and incorporating techniques or approaches in their interventions that will 
promote patient adherence and, consequently, treatment effectiveness. 
This study examined one such approach, virtual reality rehabilitation (VRR). VRR is a treatment approach that 
combines dynamic functional exercises (those that focus on lower body muscles and core stability to simulate 
common movements to prepare muscles for daily tasks) and video gaming in order to enhance motivation, 
thereby increasing participation, promoting adherence, and reducing dropout rates.[12] VRR employs computer-
generated (virtual reality) environment using widely available game consoles (e.g., Nintendo Wii, Sony 
Playstation) to guide patients through clinician-prescribed interactive functional exercises in a fun and engaging 
manner.[13] Although many randomized control trials (RCTs) have demonstrated the effectiveness and 
motivational advantages of VRR-delivered therapies for various conditions and patient populations (e.g., those 
with stroke or balance problems),[14-16] no study has yet evaluated the effects of this novel treatment 
approach on urinary incontinence treatments and, more specifically, for older women with UI. Therefore, this 
feasibility study was necessary to determine if VRR (functional training) combined with PFM training 
(contractions) is a feasible treatment approach with older women with MUI; that is, would they participate in, 
comply to and complete the combine PFM/VRR program demands. 
The objectives of this quasi-experimental pre-test, post-test pilot study were (1) to evaluate the feasibility of 
using a PFM/VRR program to treat MUI in older women, (2) to evaluate the effectiveness of the PFM/VRR 
program on MUI symptoms and quality of life (QoL), and (3) to gather quantitative information regarding patient 
satisfaction with the PFM/VRR training program. In the present study, feasibility is defined as the participants' 
rate of participation and completion for both the PFM/VRR training and the home exercise components. 
 
 
MATERIALS AND METHODS 
Participants 
Community-dwelling women were recruited through newspaper advertisements and promotional activities in 
seniors' organizations. Participants were included if they were female, aged 65 years and older, lived at home, 
were ambulatory (i.e., able to walk indoors/outdoors without any assisted devices), understood French or 
English (verbal and written instructions), had not changed their hormone prescription within the last 6 months, 
and suffer from MUI. MUI was defined by an affirmative answer to questions 2 and 3 of the short Urogenital 
Distress Inventory (UDI).[17] This validated indicator of UI has been previously used in non-experimental and 
randomized controlled trials.[18, 19] In addition, a history of urinary leakage secondary to urgency and physical 
exertion, coughing or sneezing, at least twice a week or more, within the last 3 months, was required for 
inclusion. 
Participants were excluded if they had chronic constipation (per the Rome III criteria),[20] a pelvic organ 
prolapse of grade II or more according to the pelvic organ prolapse quantification system (POP-Q),[21] or 
perineal pain; were taking medication known to affect continence; or had mobility, medical or psychological 
problems that would interfere with the physical assessment or the PFM exercise program. 
Participant eligibility using the above criteria was assessed by a questionnaire completed during a telephone 
interview with a research assistant. 
The study received ethical approval from the Comité d'éthique de la recherche de l'Institut Universitaire de 
Gériatrie de Montréal and written consent was obtained from each participant prior to the first evaluation. 
Intervention Protocol 
Each woman participated in two pre-intervention evaluations (pre-1 & pre-2) followed by a 12-week PFM/VRR 
training program and one post-intervention evaluation (post). The first two evaluations were conducted 2 weeks 
apart to ensure consistency in the incontinence measures prior to the intervention. They were identical; both 
included an interview using the same three questionnaires (UDI-6, the IIQ and the ICIQ-UI) and a modified 1-hr 
pad test.[22] However, demographic, medical and gynaecological history was only taken in the first evaluation 
(pre-1). All three evaluations were done by the same experienced physiotherapist (VF). 
The 12-week intervention was delivered to groups of eight participants in a weekly 60-min exercise class under 
the supervision of another experienced physiotherapist (VE). Each session included a 10-min education period, a 
30-min session of static PFM and deep abdominal (transverse abdominis [TrA]) training in different static 
positions as lying, sitting, four point kneeling and standing feet apart. The exercise class ended with a 20-min 
VRR training using a dance game, StepMania with dynamic PFM training. Participants were also given a 20-min 
static PFM home exercise program to do at home, 5 days per week. A weekly exercise diary was provided to 
each participant in which to record their home exercise participation. Details of the intervention protocol and 
progression are described in Appendix I. 
The virtual reality component of the class session used a computer with a freeware dance game program, 
StepMania (www.stepmania.com), to create a virtual environment. Stimuli in the dance game were five 
instrumental songs paired with visual cues on how to dance each music track (i.e., arrows indicating step 
movements in four cardinal directions). A sequence of scrolling arrows that moved upwards on the screen cued 
each move (lower extremity movements); the participant had to make the indicated step on the dance mat 
when the relevant arrow reached the top of the screen. Different arrow sequences were generated for all five 
tracks. PFM contractions were represented by a red dot incorporated into the sequence of arrows as part of the 
combined functional PFM training exercise (see Fig. 1). In sum, the PFM strengthening component was provided 
through the addition of the PFM training component (i.e., PMF contractions) which preceded the VRR functional 
component (the step movements). 
 
Figure 1. Example of the dance game series of arrows that included a PFM contraction represented by the red dot. 
Outcome Measurements 
Feasibility 
Feasibility was defined as the participants' rate of participation and completion of both the PFM/VRR training 
and the home exercise programs. Class participation was calculated as the number of classes attended by each 
participant against the overall number of classes offered (a maximum of 12). Participants were required to 
complete at least 10 classes to be considered as having completed the intervention. The completion rate for the 
PFM/VRR training program was calculated as the proportion of participants who completed the final 
assessment. Participation in the home exercise program was calculated by summing up the adherence frequency 
for the home exercises over the 12-week period: participants were asked to record each time they completed 
the home exercises in their weekly exercise diary. Attrition was measured as the number of participants lost at 
follow-up. 
Effectiveness of the intervention on MUI symptoms and QoL 
The effectiveness of the PFM/VRR training program on MUI symptoms and on QoL was evaluated using 
measures of urinary leakage, frequency, and quantity; patient reported symptoms; and quality of life. 
To evaluate the frequency of UI leakage, the 72-hr (3-day) bladder diary was used. The diary included questions 
on the number of leakage episodes, provoking factors related to leakage, and the time and number of 
micturition, as well as the number of protections (sanitary pads) used during the 3-day period. 
The usual 1-hr pad test[23] had to be adapted in order to include functional tests for older adults (see Appendix 
II). Thus to evaluate the quantity of urinary leakage, a modified 1-hr pad test was used with a standardized 
bladder volume, using a bladder scan; 300 ml was the required minimum to proceed with the test. To 
accommodate for sweating and vaginal discharge, up to 2 g of weight gain in the pad test was considered an 
indication of continence.[22] 
To measure patient-reported symptoms and QoL, the short form of the Urogenital Distress Inventory (UDI-6), 
the Incontinence Impact Questionnaire (IIQ), and the ICIQ-UI were used. All three assessed the presence of 
various urogenital symptoms and their effect on QoL. 
The five outcome measures, the 72-hr bladder diary, the 1-hr pad test, the UDI-6, the IIQ and the ICIQ-UI, have 
been found to be valid and reliable measures of incontinence symptoms and UI-related QoL in women.[17, 22, 
24-26] 
Participant satisfaction with treatment 
To evaluate participant's treatment satisfaction, a visual analogue scale (VAS) for satisfaction and a 
questionnaire were used at the end of the PFM/VRR intervention period. Participants' overall assessment of 
their satisfaction with the VRR component was recorded on a 10 cm VAS using the words “not satisfied” and 
“extremely satisfied.”[27] Participants were also questioned regarding their satisfaction with the treatment 
received. Only two responses were possible: “satisfied,” indicating that the participant did not want another 
treatment, and “dissatisfied,” indicating that the participant wanted an alternative treatment to the one 
provided in the study.[3] 
Perception of improvement 
Participants' perception of improvement at the end of the intervention period was also measured using an 
Estimated Percent Improvement (EPI) question that rated the participant's improvement on a percentage 
scale.[28] 
Sample Size Justification and Statistical Analysis 
Based on previous work, a priori power calculation (α = 0.05, β = 0.90) was performed and determined that 20 
participants were needed to detect a significant change in the pad test, mean UI episode/day for the 72-hr 
urinary diary and IIQ. The sample size was set at 24, to allow for dropouts. 
Analyses were performed with the SPSS software, version 19 (IBM SPSS Statistics, New York). The significance 
level was set at 0.05 for all tests. Descriptive analysis was used for class and home exercise participation, 
participant satisfaction with treatment outcomes, and perception of improvement. Data from the questionnaires 
and the 72-hr bladder diary were normally distributed; hence each of the outcome measures for the three 
evaluations (pre-1 & -2 and post) were compared using repeated measures analysis of variance (ANOVAs). Data 
for the modified 1-hr pad test were not normally distributed, hence, were compared using the non-parametric 
repeated measures comparison (Friedman test). For effect size, we used r; suggested norms for interpreting r 
are: 0.1 = small, 0.3 = moderate, and 0.5 = large effect.[29] 
RESULTS 
Participant Baseline Characteristics 
Twenty-four women participated in the study and had the following means and standard deviations (SD): age 
70.5 (3.6) years, body mass index of 25.9 (3.6) kg/m2, hysterectomy 0.7 (0.5) and pregnancy 1.7 (1.4), including 
1.3 (1.3) vaginal deliveries and 0.1 (0.3) Caesarean sections. 
Feasibility: Participation and Completion 
The majority of participants complied with the study demands in terms of attendance at the weekly treatment 
sessions (91.0%), adherence to the home exercise program (92.0%) and completion of the three (pre-1, pre-2 
and post) evaluations (96.0%). The assessments and intervention were well tolerated, with an attrition rate of 
4.0%. Only one participant was unable to complete the physical part of the post-intervention evaluation due to 
an acute ankle injury not related to the intervention. 
Effectiveness of Intervention on UI Severity and QoL 
There was no significant difference between the pre-1 and pre-2 evaluations for the 72-hr urinary diary (mean 
voiding, leakage, and protections per day) nor in the UDI-6, IIQ, and ICIQ-UI scores, showing stability of UI and 
QoL measures in the absence of the intervention (Table I). Except for the mean protection measured in the 72-hr 
urinary diary, there was a significant improvement for all UI and QoL outcomes in the post evaluations as 
compared to both the pre-1 and the pre-2 evaluations (Table I). 
Table I. UI PFM/VRR Responsiveness Outcomes Using Repeated-Measures ANOVA (n = 24) 
 Ou
 Pre-11 mean & SD  Pre-22 mean & SD  Post3 mean & SD  Statistic test & P-value 
 72
 8.62 (3.01)  7.88 (2.64)  6.79 (2.10)  F(2.22)19.39 P ¼ 0.000* 
    P1–2 ¼ 0.060 (95% IC -0.023, 1.496)     P2–3 ¼ 0.008*  (95% IC 0.258, 1.937)     P1–3 ¼ 0.000*  (95% IC -2.577, -1.090) 72 1.51 (1.34) 1.19 (1.13) 0.51 (0.49) F(2,22) 8.93 P ¼ 0.001*     P1–2 ¼ 0.151 (95% IC -0.080, 0.719)     P2–3 ¼ 0.010*  (95% IC 0.143, 1.218)     P1–3 ¼ 0.001*  (95% IC -1.597, -0.403) 72 0.90 (0.81) 0.77 (0.90) 0.47 (0.88) F(2,22) 5.42 P ¼ 0.012*     P1–2 ¼ 0.525 (95% IC -0.11, 0.36)     P2–3 ¼ 0.125 (95% IC -0.06, 0.67)     P1–3 ¼ 0.010*  (95% IC -0.77, -0.09) UD 47.05 (15.47) 42.01 (14.16) 19.79 (11.14) F(2,22)30.53 P ¼ 0.000*     P1–2 ¼ 0.448 (95% IC -3.68, 13.75)     P2–3 ¼ 0.000*  (95% IC 14.35, 30.09)     P1–3 ¼ 0.000*  (95% IC -37.56, -16.96) II 70.44 (39.83) 58.64 (48.38) 24.62 (33.14) F(2,22)10.41 P ¼ 0.001*     P1–2 ¼ 0.205 (95% IC -4.14, 27.75)     P2–3 ¼ 0.007*  (95% IC 8.40, 59.63)     P1–3 ¼ 0.000*  (95% IC -71.33, -20.32) Sh 11.13 (3.35) 10.21 (3.77) 5.00 (3.470) F(2,22)24.51 P ¼ 0.000*     P1–2 ¼ 0.871 (95% IC -1.27, 3.10)     P2–3 ¼ 0.000*  (95% IC 2.68, 7.73)     P1–3 ¼ 0.000*  (95% IC -8.38, -3.87) 
Of the 24 participants, only 14 were able to reach a bladder volume of 300 ml before starting the modified 1-hr 
pad test. However, secondary to an acute ankle injury, one of the 14 participants was unable to complete the 
physical part of the post-treatment evaluation. Applying a P = 0.017 Bonferroni adjustment, among those 
participants with a bladder volume 300 ml, the modified 1-hr pad test changed significantly between pre-1 and 
post (n = 13, T = 0, P = 0.008, r = −0.74) and pre-2 and post (n = 13, T = 55, P = 0.005, r = 0.78), but not between 
pre-1 and pre-2 (n = 13, T = −1, P = 0.313, r = −0.28). 
Treatment Satisfaction 
According to the satisfaction VAS, the mean appreciation score of the VRR component in the training program 
was 9.8/10 (0.5). The satisfaction question revealed that 91.0% of the participants were satisfied with the overall 
PFM/VRR training program and would not seek additional treatment. 
Perception of Improvement 
The mean percent improvement of the UI condition estimated by the participants was 72.3% (22.7%). More than 
half of the group (54.0%) reported ≥75.0% improvement; only one participant reported a low improvement of 
15.0%. 
DISCUSSION 
This feasibility study is the first to explore the use of VRR, which combines functional exercises and video 
gaming, as a complimentary component to PFM conventional rehabilitation. It demonstrated that women aged 
65 and over, with MUI, are good candidates for a PFM/VRR training program and are capable of complying with 
study demands, as demonstrated by the high participation and low attrition rates. 
In fact, all outcomes for responsiveness to the PFM/VRR training program showed a statistically significant 
improvement between the pre-2 evaluation, which took place just before the 12-week PFM/VRR training 
program, and the post-intervention evaluation (P-value range [P = 0.00–0.01]). Further, the improvements in UI 
symptoms and in QoL are also supported by the absence of statistically significant changes in any of the 
responsiveness outcome measures (P-value range [P = 0.06–0.87]) between the first two evaluations, pre-1 and 
pre-2. 
When evaluating the validity of a study it is important to consider both the clinical and statistical significance of 
the findings.[30] Studies that claim clinical relevance may lack sufficient statistical significance to make 
meaningful statements or, conversely, may lack practicality despite showing a statistically significant difference 
in treatment options. Researchers and clinicians should not focus on small P-values alone to decide whether a 
treatment is clinically useful; it is necessary to also consider the magnitude(s) of treatment differences and the 
power of the study.[30] Encouraging in this context is the observation that the majority of the pre-post 
intervention comparisons showed high magnitude(s) for the observed differences. The “minimum clinically 
important difference” (MCID) was reached for each of the responsiveness outcomes between the pre-2 and post 
evaluations. The MCID for the mean UI episodes, using the 72 hr bladder diary, is a 50.0% reduction[31]; the 
study showed a 58.0% reduction. Similarly, the MCID for the UDI-6 score is a 10-point reduction[32]; this study 
demonstrated a 22-point decrease. The MCID for the IIQ score is a decrease of 10–25 points[33]; the study 
showed a 34-point decrease. Additionally, the study found a five-point reduction in the ICIQ-UI score; the MCID 
is only a two-point reduction.[34] Finally, the MCID for the pad test is a 50.0% reduction in urinary leakages[35]; 
the present study showed an 85.0% reduction. Therefore, the PFM/VRR training program was effective in 
reducing UI symptoms and enhancing QoL to a clinically significant degree. 
Four studies, one cohort and three RCTs on PFM training groups, used PFM exercises classes to treat older 
women with UI, hence, can be compared to the present study.[2-4] 
Interestingly, the mean attendance rate to the weekly treatment sessions for the present study (91.0%) was 
higher than that obtained by the Dumoulin cohort study (82.2%) as well as that of Kim and collaborators (2007) 
in their RCT (82.4%). Further, the completion rate of the present study (96.0%) was also higher than those 
obtained by the Dumoulin study (80.8%) and the RCTs conducted by Kim (2007), Pereira (2011), and Sherburn 
(2011; 88.0–95.0%). While these differences may, in part, be attributable to the VRR component, they could also 
be linked to differentials in age, UI type and treatment delivery with the present study. At 65 and older, the 
participants in the present study were the same age as in the Sherburn study, but slightly younger than those in 
Kim's (70+) and slightly older than those in Dumoulin's (60+) and Pereira's (60+). While this study focused 
exclusively on MUI, Dumoulin's study focused on both MUI and SUI, and the remaining studies—Sherburn, 
Pereira, and Kim—focused exclusively on SUI. Finally, the frequency of treatment, hence an increased 
participation burden, was also higher in Kim's study (twice a week) compared to this study (once per week). As 
suggested by the comparative results, the VRR program may have enhanced treatment adherence and 
completion rates; however, slight variations between this study's and the four studies' protocols render a degree 
of uncertainty, which needs to be explored through further randomized control trials (RCTs). 
In addition to the above, variations in incontinence outcomes were also noted, but, again, these could also be 
attributable to variations in the data collection methods. Following treatment, Perreira's RCT (2011), which used 
the 1-hr pad test,[23] recorded an average reduction of 1.42 g (n = 17) compared to 31.13 g for the present study 
(n = 13). However, while both used a 1-hr pad test, the present study adapted Pereira's pad test to include 
functional fitness tests (the results of which have been presented in a scientific abstract[36]); specifically, the 
walking component at the beginning of the test was divided into standing functional fitness tests and the stair 
climbing component was replaced by more walking and an additional minute of light running. 
As in this study, Sherburn's RCT (2011) also used the ICIQ-UI to measure the presence of various urogenital 
symptoms and their effects on QoL. Sherburn noted a mean post-treatment improvement of 4.5 points 
compared to 5.21 points for the present study. The intervention protocols for both studies included education 
periods and strengthening exercises for pelvic floor and abdominal muscles in different positions, but only this 
study used VRR. Both Dumoulin's and this study included the IIQ and a 72-hr bladder diary. The mean reduction 
(%) in the number of daily UI episodes post-treatment was 48.0% in Dumoulin's study compared to 58.0% in the 
present study. For the IIQ, the mean improvement post-treatment was 16.83 points for Dumoulin's study, 
compared to 34.02 points for the present study. Although, not as dynamic as the VRR component, Dumoulin's 
intervention also included trunk and leg strengthening sessions. 
Thus, it is possible that the VRR component, specifically the expert level which required participants to contract 
their PFMs while doing a dance move, helped participants in the present study to develop their ability to 
contract their PFMs during physical activities, which could, in part, explain the difference in pad testing (with 
Perreira's) and the ensuing functional improvements reflected in both the ICIQ-UI (Serburn) and IIQ (Dumoulin) 
scores. However, it is impossible to reach a definitive conclusion without further RCTs. 
Noteworthy and further supporting the need for more research on VRR, the 91% satisfaction rate among 
participants in the present study was somewhat higher than that obtained in the group and individual 
treatments in Pereira's RCT, 86%. Further, the VRR component of the training program was highly appreciated 
by all study participants as demonstrated by a mean satisfaction VAS scores of 9.8 over 10. The addition of the 
VRR component offers a potential explanation for the increased satisfaction rating, which may have also 
facilitated treatment adherence but, again, requires further testing as a hypothesis. 
Even more interestingly, the mean estimated percent of UI-condition improvement in the present study was 
72.33%, which was higher than the actual mean reduction in incontinence episodes, 58%, documented in the 72-
hr urinary diary. In other words, participants' subjective rating for percent improvement was higher than the 
actual improvement. Participants' estimated percentage of improvement seems to not only reflect actual 
improvements in the frequency of urinary leakages, as reported in their diaries, but may also reflect an increased 
confidence in their ability to self-manage their UI. Thus, the estimated percent of improvement, as reported by 
participants, suggests that beyond the reduction or elimination of urinary leakages, there may be other factors 
equally important to UI management, such as confidence or the ability to deal with everyday situations that 
could cause urinary leakage, which the VRR component may have helped to address. 
According to the results of this feasibility study, the advantages of integrating VRR to a conventional PFM 
training are:[1] it seems to increase short-term adherence and participation by introducing a game-like aspect to 
the training program and[2] introducing PFM contractions into the virtual reality dance game appears to help 
participants to develop their ability to contract PFMs during movement. This latter has useful applications to 
everyday situations, such as retaining urine while walking to the toilet. Another potential advantage of the 
combined PFM/VRR program, which has not been discussed in this manuscript, is its potential beneficial effect in 
terms of improved executive functions, which is interesting as recent evidence suggests that older women with 
MUI demonstrate a decline in executive-function.[37] Furthermore, it could also be beneficial in improving dual-
task gait in older women with MUI. The effects of the PMF/VRR program on executive functions and dual-task 
gait in older women with MUI are described in detail by Fraser et al. in The effects of combined pelvic floor 
muscle training and virtual-reality dance rehabilitation on dual-task gait and cognition in women with mixed-
urinary incontinence, submitted recently to the Arhcives of physical therapy. 
Limitations of the Study and Further Research 
As this was a feasibility study, the sample size was limited and methodology did not include a control group; 
hence, the clinical applications of this study are limited. However, the positive results found in this study, in 
terms of feasibility, effectiveness, and participant's appreciation of the combined intervention, support the need 
for an RCT to compare this novel PFM/RRV training program to the absence of treatment and, eventually, 
standard conventional PFM training programs for the treatment of UI in elderly women. Based on the results of 
this study, minor modification should be made in the study outcomes of further RCTs. The quantity of urinary 
leakage should be measured by a 24-hr pad test in order to eliminate the lengthy and difficult process of bladder 
filling engendered by the 1-hr test. As we have hypothesized that the PFM/RRV training program could have 
impacted confidence with its functional component, self-efficacy outcome measures such as the Brooms 
questionnaire should be included in future studies.[38] The treatment protocol should remain the same as it was 
appreciated by the participants. Future RCTs should also include long-term follow-up to evaluate whether the 
treatment effects of PFM/VRR training programs can be sustained over time, in particularly as adherence is not 
only a problem during the intervention phase but also post-intervention. Finally, the data for this feasibility 
study should be used to calculate the sample size of the future RCT comparing conventional PFM trainings with 
and without VRR. 
CONCLUSION 
A combined PFM/VRR is an acceptable functional training approach for older women with MUI, one in which 
they are capable of complying with treatment program demands. Not only is it effective in reducing UI 
symptoms and in enhancing QoL but has a high level of patient satisfaction. This new approach, combining 
dynamic functional exercises and video gaming, could potentially increase participant adherence to UI treatment 
programs; however, this remains to be tested. 
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Appendix I: Intervention Protocol 
TABLE AI. Topics Discussed During the Education Period of the Weekly Class 
 
Week 1 Week 2 Week 3 Week 4 
 
Anatomy of the PFM Pathophysiology of UI Risks factors of UI Constipation  
prevention Definition  of  UI   Evacuation technique 
 
Week 5 Week 6 Week 7 Week 8 
 
Foods that irritate the bladder Hydration Advice to suppress urges Bladder retraining program 
 
Week 9 Week 10 Week 11 Week 12 
 
Protection use Integration of the PFM exercises into daily life Adherence to exercises Question period 
  
TABLE AII. Progression of the PFM and VRR Components of the Class 
 
PFM and deep 
abdominal  (TrA) 
exercises 
component 
 
 
 
Weeks 1–4 Weeks 5–8 Weeks 9–12 Position 
 
 PFM 
maximal 
 3 sets of 8 contractions x 6 sec 
 3 sets of 10 contractions x 8 sec 
 3 sets of 12 contractions x 10 sec 
 Standing, sitting, 
and supine contraction     The knack 3 sets of 3 cycles of one 3 sets of 3 cycles of one 3 sets of 3 cycles Standing  PFM contraction, cough PFM contraction, cough, of one PFM contraction,   and PFM relaxation and PFM relaxation cough and PFM     relaxation  The podium 3 podiums; 6 sec 3 podiums; 8 sec per level 3 podiums; Sitting  per level  10 sec per level  TrA contraction Supine knee flexed, Supine knee flexed, Supine knee flexed, Supine knee flexed  1 set of 10 TrA 1 set of 10 TrA 1 set of 10 TrA   contractions x 5 sec combined with contractions x 5 sec combined with a sit-up contractions x 5 sec combined   alternating hip  with alternating   extension  diagonal sit-up  TrA contraction Four point kneeling, Four point kneeling, Four point kneeling, Four point kneeling against gravity 1 set of 10 TrA 1 set of 10 TrA 1 set of 10 TrA   contractions x 5 sec contractions x 5 sec combined with alternating contractions x 5 sec combined with    arms elevation alternating     legs elevation  VRR component Beginner level: 4 songs Intermediate level 4 Expert level: 4 songs Idem Standing dancing game  One foot at a time songs The right and left foot are simultaneously intermediate þ red dot representing a    not doing the same PFM contraction    dance step    
TABLE AIII. PFM Home Exercises and Progression 
 
Exercise Weeks 1–4 position: supine Weeks 5–8 position: sitting Weeks 9–12 position: standing 
 
PFM maximal voluntary contraction 3 sets of 8 contractions x 6 sec 3 sets of 10 contractions x 8 sec 3 sets of 12 contractions x 10 sec 
The knack 3 sets of 3 cycles of one 
PFM contraction, cough 
and PFM 
relaxation 
3 sets of 3 cycles of one 
PFM contraction, cough and 
PFM relaxation 
3 sets of 3 cycles of one 
PFM contraction, cough and 
PFM relaxation 
The podium  3 podiums; 6 sec per level 3 podiums; 8 sec per level  3 podiums; 10 sec per level 
The rapid PFM contractions 3 sets of 6 rapid contractions 3 sets of 8 rapid contractions 3 sets of 10 rapid 
contraction 
 
 
 
Appendix II: The Modified 1 hr Pad Test 
 
• Women  had  to  drink  500 ml  of  water  1 hr  before  the evaluation. • At the beginning of the evaluation, bladder quantity was measured by ultrasound (Bladder scan 3000, Diagnostic Ultrasound) and a minimum of 300 ml was necessary to proceed with the modified 1-hr pad test. The modified 1 hr pad test sequence was as followed:  
• three timed up and go tests, • two 2-min walk tests, • three repetitions of the unipodal stance test on the dominant leg, • 10 repetitions of sit to stand from a toilet, • picking up five objects from the ground, • 1 min of hand washing, • two sets of 1 min of light running, • 30 min of walking with and without a cognitive task.  
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